1. Home
  2. Live Updates
  3. Patients with hormone receptor positive

Patients With Hormone Receptor Positive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patients with hormone receptor positive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patients With Hormone Receptor Positive Today - Breaking & Trending Today

Endocrine Therapy Response Status Is Necessary for Treatment Planning in HR+/HER2– Early Breast Cancer

Beyond genomic testing, endocrine therapy response should be used to determine whether patients with hormone receptor–positive, HER2-negative, N0-1 early breast cancer. ....

San Antonio , United States , West German , Oleg Gluz , German Study Group , Antonio Breast Cancer , West German Study Group , Adaptcycle Trial , The Addition Of Ovarian Function Suppression To Endocrine Therapy , Patients With Hormone Receptor Positive , Er2 Negative Early Breast Cancer ,

MammaPrint Predicts Likelihood of pCR With Neoadjuvant Chemo in HR+/HER2– Early Breast Cancer

Real-world data support the use of the MammaPrint index as a predictor of neoadjuvant chemosensitivity in patients with hormone receptor–positive, HER2-negative early-stage breast cancer. ....

San Antonio , United States , Antonio Breast Cancer , San Antonio Breast Cancer Conference , Mammaprint Index , Patients With Hormone Receptor Positive , Er2 Negative Early Stage Breast Cancer ,

Capivasertib Maintains QOL Benefit Vs Placebo in HR+/HER2– Advanced Breast Cancer

Capivasertib plus fulvestrant did not negatively affect quality of life compared with placebo plus fulvestrant in patients with aromatase inhibitor–resistant, hormone receptor–positive, HER2-negative advanced breast cancer.
....

San Antonio , United States , Capivasertib Truqap , Mafalda Oliveira , Department Of Medical Oncology At Vall , Hebron University Hospital , Antonio Breast Cancer , Medical Oncology , Patient Global Impression , Treatment Tolerability , Capivasertib Plus Fulvestrant , Patients With Hormone Receptor Positive , Her2 Negative Breast Cancer , Capitello 291 Trial , Valld X27 Hebron University Hospital ,

Dr Mayer on the Use of CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

Erica L. Mayer, MD, MPH, discusses findings from research investigating CDK4/6 inhibitors in patients with hormone receptor (HR)–positive, HER2-negative breast cancer. ....

Erical Mayer , Breast Cancer Clinical Research , Dana Farber Cancer Institute , Harvard Medical School , Dana Farber And Brigham Womens Hospital , Cdk4 6 Inhibitors , Patients With Hormone Receptor Positive , Her2 Negative Breast Cancer ,

Dr Modi on Updated OS Data From the DESTINY-Breast04 Trial of T-DXd in HER2-Low Breast Cancer

Shanu Modi, MD, discusses updated survival data from the phase 3 DESTINY-Breast04 trial evaluating fam-trastuzumab deruxtecan-nxki in patients with HER2-low metastatic breast cancer.
....

Memorial Sloan Kettering Cancer Center , Shanu Modi , Trastuzumab Deruxtecan In Patients With Her2 Low Breast Cancer , Patients With Unresectable Or Metastatic Her2 Low Breast Cancer , Destiny Breast04 Trial , Patients With Hormone Receptor Positive , Her2 Low Metastatic Breast Cancer ,